局部复发直肠癌根治性治疗后再复发分析
本研究回顾性分析了33例在Catharina医院接受局部复发直肠癌(LRRC)多模式根治性治疗后的再复发(re-LRRC)病例,通过多学科会议逐一评估再复发位置、是否遵循放疗靶区(TV)方案及回顾性治疗差异。结果显示15/33(46%)再复发位于既往放疗靶区内,48%病例照射与当前TV建议一致,13/33例若按今日标准TV会改变;作者认为多达半数病例的治疗管理可能改善。
要点
- 33例LRRC根治性治疗后re-LRRC中,15/33(46%)位于既往放疗靶区内,可能提示放疗抵抗。
- 17/33例LRRC治疗被认为欠佳,原因包括靶区不同(13/17)和/或手术不同(9/17)。
- 回顾性分析中48%病例照射与当前TV建议一致,13/33例若今日照射TV会改变。
核心结论
- 本研究强调当前LRRC标准治疗存在改进空间,不同手术管理或TV可能改善多达半数讨论病例的结局。
- 进一步制定勾画指南并纳入本研究结果,可能改善LRRC患者的肿瘤学结局,特别是局部控制。
研究设计与样本
- 回顾性病例分析,纳入2016年10月起在Catharina医院接受LRRC根治性治疗且具备完整(再)LRRC影像和放疗资料的患者,共33例。
- 每例在多学科全体会议中由结直肠外科专家、放射肿瘤科医生和放射科医生讨论,依据re-LRRC位置、是否符合(当前)放疗方案以及回顾性多模式管理是否会不同进行分类。
主要发现
- 33例中17例LRRC治疗被认为欠佳,其中13/17例因靶区不同,9/17例因手术不同。
- re-LRRC位于既往放疗TV内15/33(46%),可能显示放疗抵抗疾病;野外5例(15%),边缘6例(18%),混合方式7例(21%)。
- 回顾性分析中48%病例的照射与当前TV建议一致,13/33例若今日照射TV会改变。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Substantiating data guiding clinical decision making in locally recurrent rectal cancer (LRRC) is lacking, specifically in target volume (TV) definition for chemoradiotherapy (CRT). A case-by-case review of local re-recurrences (re-LRRC) after multimodal treatment for LRRC was performed, to determine location of re-LRRC and assess whether treatment could have been improved. METHODS: All patients treated with curative intent for LRRC at the Catharina Hospital Eindhoven from October 2016 onwards, in whom complete imaging of (re-)LRRC and radiotherapy was available, were retrieved. Patients were discussed in plenary meetings with expert colorectal surgeons, radiation oncologists and radiologists. Each case was classified based on re-LRRC location, whether it was in accordance with the (current) radiotherapy protocol, and whether multimodal management would have been different in retrospect. RESULTS: Thirty-three cases were discussed. LRRC treatment was deemed suboptimal in 17/33 patients, due to different target volumes (13/17) and/or different surgery (9/17). 15/33 (46 %) of re-LRRC developed in-field of the prior radiotherapy TV, possibly showing RT-resistant disease. Other re-LRRCs developed out-field (n = 5, 15 %), marginally (n = 6, 18 %), or in a combined fashion (n = 7, 21 %). In retrospect, 48 % of cases were irradiated in line with current TV recommendations. TVs of 13/33 cases would have been altered if irradiated today. CONCLUSION: This study highlights room for improvement within current standard-ofcare treatment for LRRC. Different surgical management or TVs may have improved outcome in up to half of discussed cases. Further delineation guideline development, incorporating the results from this study, may improve oncological outcome, specifically local control, for LRRC patients.
引用
- Piqeur F, Coolen L, Nordkamp S, et al. Analysis of re-recurrent rectal cancer after curative treatment of locally recurrent rectal cancer. Radiother Oncol. 2024. PMID: 39242031. doi:10.1016/j.radonc.2024.110520
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。